MLKL and chronic kidney disease: In late-stage CKD, ferroptosis and necroptosis form a positive feedback loop: ferroptosis-derived DAMPs (e.g., HMGB1) activate RIPK3–MLKL signaling, while necroptosis releases labile iron, further fueling ferroptosis.